TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BCYC

Bicycle Therapeutics Ltd

Healthcare · Biotechnology

3.40$ -5.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow BCYC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -68.7% -365.4% -207.3% -171.2% -126.5% -595.4% -224.7% -467.0% -344.0%
– 16.1% 10.0% 7.0% 12.3% 12.0% 25.5% 24.3% 20.3% 8.8%
– 25.0% 14.3% 22.3% 62.7% 103.3% 185.2% 120.4% 108.0% 54.4%
– 30.8% 23.7% 61.3% 63.4% 107.3% 153.8% – – –
– 632.1% -92.9% -53.8% 244.0% 325.4% 4.6% 284.2% -94.9% -104.4%
– 54.0% 16.6% 11.3% 11.5% 17.4% 131.3% 10.9% 3.5% 3.2%
– -54.0% -16.6% -11.3% -11.5% -17.4% -131.3% -10.9% -3.5% -3.2%
– 0.0% 0.0% – – – – – – –
– 2,809.5% -8.1% 423.4% – – – – – –
– 728.2% 210.2% 108.7% 144.4% 128.2% 0.0% 0.0% -90.4% -0.2%
– 2,809.5% 356.4% 423.4% 604.8% 2,741.9% 46.3% 926.8% 1,473.4% -0.2%
– 2,828.2% -60.0% 208.2% 422.3% 2,587.8% -688.1% 696.2% 1,001.0% -346.3%
– -122.7% -382.1% -218.6% -182.8% -143.8% -726.7% -235.6% -470.5% -348.0%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?